Remote Connectivity Among Features of Mitsubishi Electric Automation’s Newest Widescreen HMI
Sep 28, 2017 16:34 pm UTC| Business
VERNON HILLS, Ill., Sept. 28, 2017 -- Demand for operational efficiencies such as greater visualization into a factory’s automation solutions portfolio has prompted Mitsubishi Electric Automation, Inc. to introduce its...
HALF-YEAR CONSOLIDATED RESULTS: STABILITY OF NET LOSS & MAJOR PROGRESS ON R&D PROGRAMS
Sep 28, 2017 16:31 pm UTC| Business
2017 HALF-YEAR CONSOLIDATED RESULTS: STABILITY OF NET LOSS MAJOR PROGRESS ON RD PROGRAMS IN HEALTH, NUTRITION AND COSMETICS · Cash position: +€6.6m at June 30, 2017 compared to +€9.3m at December 31,...
Sep 28, 2017 16:31 pm UTC| Business
Nanobiotix plans to conduct its first clinical trial with NBTXR3 in combination with immune checkpoint inhibitors in the U.S. Multi-arm trial targets sub-population of advanced lung, and head and neck cancer...
Game Plan Releases Virtual Mentorship
Sep 28, 2017 16:30 pm UTC| Business
GREENVILLE, N.C., Sept. 28, 2017 -- Game Plan, the comprehensive athlete development platform that unifies and aligns athletic organizations, athletes, and employers, is thrilled to announce the release of Virtual...
Zignal Labs Continues Expansion with Opening of New York City Office and Strategic Executive Hires
Sep 28, 2017 16:20 pm UTC| Business
SAN FRANCISCO, Sept. 28, 2017 -- Zignal Labs today announced its expansion to New York City and new executive hires. Zignal’s new office in New York City will service its growing base of enterprise clients across the...
Nasdaq Welcomes Roku, Inc. (Nasdaq: ROKU) to The Nasdaq Stock Market
Sep 28, 2017 16:16 pm UTC| Business
NEW YORK, Sept. 28, 2017 -- Roku, Inc. (Nasdaq:ROKU), a pioneer in the TV streaming industry, rang the opening bell at the Nasdaq MarketSite in Times Square today in celebration of its initial public offering (IPO) on...
Sep 28, 2017 16:09 pm UTC| Business
EAGAN, Minn., Sept. 28, 2017 -- Biothera Pharmaceuticals, Inc. today announced that it will present new research at three upcoming healthcare conferences for Imprime PGG, Biothera’s novel phase 2 cancer immunotherapy....